Amgen, Ipsen vet moves up the ladder with Coherus' anti-PD-1 awaiting PDUFA; It takes a village to replace Frank Clyburn at Merck's Human Health business
After decades in the biopharma industry, Paul Reider is now in his first C-suite role as chief commercial officer. While he has been at …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
